Article -> Article Details

Market Overview

The global pediatric vaccines market\ size was USD 39.7 Billion in 2024 and is forecasted to reach USD 72.7 Billion by 2033, growing at a CAGR of 6.89% during the forecast period 2025-2033. Key growth factors include the conduction of extensive vaccination programs, the increasing focus on combination vaccines, and rising partnerships between pharmaceutical companies and healthcare organizations to fast-track vaccine development and distribution. 

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033

Pediatric Vaccines Market Key Takeaways

• The global pediatric vaccines market size was USD 39.7 Billion in 2024.
• The market is expected to grow at a CAGR of 6.89% during 2025-2033.
• The forecast period for the market is 2025-2033.
• Increasing occurrence of infectious and life-threatening diseases such as polio, tuberculosis, and malaria among children is driving market growth.
• Rising government initiatives worldwide to immunize children against preventable diseases are supporting market expansion.
• Growing technological advancements in vaccine storage and distribution methods are improving supply chains in less developed regions.
• Strategic partnerships between pharmaceutical companies and healthcare organizations are accelerating vaccine development and distribution.
• The rising construction of healthcare facilities like clinics and hospitals globally is bolstering market growth.

Sample Request Link: https://www.imarcgroup.com/pediatric-vaccines-market/requestsample

Market Growth Factors

More people adopting vaccination programs causes the market for pediatric vaccines to grow. Support by governments and non-governmental organizations has increased the number of vaccinations among children. Preventive measures for disease reduce childhood illness incidence, lessen burden on healthcare systems and family caretakers, and improve children's life quality.

An emerging trend observed in the pediatric vaccines market is the increased demand within combination vaccines. Combination vaccines combine ease of use and comply better for healthcare workers and parents, which can improve coverage rates. Combination vaccines may help if people hesitate about vaccines and miss doses by reducing how much people think about multiple injections and improving adherence to schedules.

Developing new vaccines for various applications increasingly, especially for infectious diseases in children, drives the increased demand in a major way. Genomics and bioinformatics help with the identification of vaccine candidates and their successful production. Public health authorities, research institutions, and manufacturers coordinate to ease rapid development and deployment as they respond to changing epidemiological patterns.

Market Segmentation

Breakup by Type:

• Multivalent: Dominates the market, these vaccines provide protection against multiple diseases in a single injection, streamlining vaccination, reducing discomfort for children, and optimizing healthcare resources by combining vaccines into one formulation.
• Monovalent: Included in segmentation but no descriptive detail provided in source.

Breakup by Technology:

• Conjugate: Holds the largest market share; these vaccines enhance immune response by linking bacterial polysaccharides to proteins, especially benefiting young children, reducing bacterial carriage and contributing to herd immunity.
• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Others

Breakup by Application:

• Infectious Disease: Pediatric vaccines provide immunity against pathogens, contributing to children's health.
• Cancer: Vaccines prevent certain cancers primarily affecting children by targeting infections like HPV and HBV, allowing early prevention and reducing cancer risk.
• Allergy: Vaccines bolster immune response to lessen allergy development to common allergens.
• Others

Regional Insights

North America dominates the pediatric vaccines market due to high investments in vaccine research for preventing infectious and chronic diseases. Increased awareness among parents about immunization importance and improved healthcare infrastructure for quality treatment further support market growth. Asia Pacific is forecasted to expand due to rising infectious diseases caused by novel viruses and government initiatives promoting vaccination significance among children.

Key Players

• Bio-Med (P) Limited
• Daiichi Sankyo Company Limited
• GSK plc
• Indian Immunologicals Limited
• Merck & Co. Inc.
• Panacea Biotec
• Pfizer Inc.
• Sanofi

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request For Customization:

https://www.imarcgroup.com/request?type=report&id=6230&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302